Abstract
Despite continuous progress made in the diagnosis and therapeutic modalities, syncope management remains challenging for physicians. The role of electrophysiologic study (EPS) in the evaluation of a patient with syncope has been reviewed by several authors [1–3]. However, recent advances in diagnostic tools, such as the development of an implantable loop recorder [4,5], active clinical investigation of the potential role of pacemaker therapy in reflexogenic bradycardia [6–8], and results from the Antiarrhythmics Versus Implantable Defibrillators (AVID) study and registry [9,10] provide exciting new information on the diagnosis and therapeutic approach to patients with syncope. The overall aim of this review is to update results from the recent clinical trials and to summarize new trends in diagnosis, management, and risk stratification of patients with recurrent syncope.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
